S10 Ep43: Orlowski on Isa-VRd in Transplant-Ineligible Multiple Myeloma

from OncLive® On Air · host OncLive® On Air

Dr Orlowski discusses key efficacy data from the IMROZ trial of Isa-VRd in newly diagnosed, transplant-ineligible multiple myeloma.

Episode metadata supplied by the publisher feed · Published Jul 11, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

S10 Ep43: Orlowski on Isa-VRd in Transplant-Ineligible Multiple Myeloma

0:00 10:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 10 minutes long.

This episode was published on July 11, 2024.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!